Anti-infectives-induced adverse drug reactions in hospitalized patients
- PMID: 15844215
- DOI: 10.1002/pds.1099
Anti-infectives-induced adverse drug reactions in hospitalized patients
Abstract
Objectives: To assess the rate and seriousness of adverse drug reactions (ADRs) attributable to anti-infective agents in hospitalized patients; to estimate the likelihood of experiencing anti-infectives-induced ADRs at different length of drug usage in the hospital; to compare different classes of anti-infectives in inducing ADRs; to determine the impact of age and sex on anti-infectives-induced ADRs.
Design: Prospective cohort study.
Participants: Patients admitted to the infectious diseases department at a university teaching hospital, on Sunday to Wednesday, over a 9 months period, who received at least one anti-infective agent were eligible to enter the study.
Main outcome measures: Any suspected noxious and untoward medical events, including laboratory tests abnormalities following anti-infective therapy.
Methods: All patients admitted have received at least one anti-infective drug. Anti-infective agents induced ADRs were detected by interviewing patients and daily chart review. The seriousness, causality, and type of reactions were classified based on World Health Organization (WHO) definitions. Chi-square analysis was performed to assess the influence of sex and age on occurring ADRs. Both Kaplan-Meier and life table method were used to estimate the time to occur the ADR in anti-infective users. To compare the estimated risk of ADRs induced by different classes of anti-infectives, odds ratios were estimated. In all classes of anti-infectives, the odds ratio of each class was estimated with regard to anti-tuberculosis agents, which had the highest prevalence of ADRs.
Results: During the study period, 460 patients were entered the study. During the same period, 38 ADRs were recognized of which 20 (42%) were serious. The most recognized ADRs were suspected to be induced by anti-tuberculosis agents (29.8%). However in comparing with anti-tuberculosis agents, anti-fungal agents were associated with the highest ADR rate (odds ratio [OR], 4.21; 95% confidence interval [CI], 1.41-1.256) whereas cephalosporines were associated with the lowest rate, (OR, 0.1; 95%CI, 0.04-0.26). The survival analysis shows that the likelihood of experiencing an ADR was increased at first 14 days of drug therapy. Also Chi-square analysis shows that greater risk of anti-infectives-induced ADRs was observed in women.
Conclusion: The rate of ADRs induced by anti-infective agents in this study was 8.2%. This is higher than a standard (5%) which has been reported in other studies. This study also shows that some of the classes of anti-infective agents like anti-fungals need more attention.
Copyright 2005 John Wiley & Sons, Ltd.
Similar articles
-
Adverse drug reactions in an Iranian department of adult infectious diseases.East Mediterr Health J. 2009 Nov-Dec;15(6):1351-7. East Mediterr Health J. 2009. PMID: 20218124
-
Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors.Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1104-10. doi: 10.1002/pds.1468. Pharmacoepidemiol Drug Saf. 2007. PMID: 17823987
-
A prospective study of adverse drug reactions in a dermatology department.Methods Find Exp Clin Pharmacol. 2007 Mar;29(2):107-12. doi: 10.1358/mf.2007.29.2.1075348. Methods Find Exp Clin Pharmacol. 2007. PMID: 17440627
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.Neurourol Urodyn. 2008;27(8):738-46. doi: 10.1002/nau.20645. Neurourol Urodyn. 2008. PMID: 18951451 Review.
Cited by
-
Antimicrobial stewardship: opportunities in long-term care homes.Drugs Aging. 2011 Oct 1;28(10):765-7. doi: 10.2165/11596440-000000000-00000. Drugs Aging. 2011. PMID: 21970304 No abstract available.
-
Evaluation of anti-tuberculosis induced adverse reactions in hospitalized patients.Pharm Pract (Granada). 2006;4(3):134-8. Pharm Pract (Granada). 2006. PMID: 25214900 Free PMC article.
-
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) randomised clinical trial: study protocol.BMJ Open. 2020 May 11;10(5):e038300. doi: 10.1136/bmjopen-2020-038300. BMJ Open. 2020. PMID: 32398341 Free PMC article.
-
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): study protocol for a pilot randomized controlled trial.Trials. 2015 Apr 18;16:173. doi: 10.1186/s13063-015-0688-z. Trials. 2015. PMID: 25903783 Free PMC article. Clinical Trial.
-
Variability in antibiotic use at children's hospitals.Pediatrics. 2010 Dec;126(6):1067-73. doi: 10.1542/peds.2010-1275. Epub 2010 Nov 15. Pediatrics. 2010. PMID: 21078728 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials